XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts (Tables)
9 Months Ended
Oct. 31, 2021
Equity [Abstract]  
Fair Value Measurement Inputs and Valuation Techniques
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
February 26, 2021
(Merger Date)
January 31,
2021
Expected volatility84.3 %80.5 %
Risk-free interest rate0.0 %0.1 %
Dividend rate0.0 %0.0 %
Expected term (years)0.01.4
The Private Placement Warrants were valued using the following assumptions under the BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date:
October 31,
2021
February 26,
2021
Market price of public stock$24.78$30.83
Exercise price$11.50$11.50
Expected term (years)4.35.0
Volatility70.5 %73.5 %
Risk-free interest rate1.0 %0.8 %
Dividend rate0.0 %0.0 %
Assumptions used in the valuation are described below.
March 12,
2021
February 26,
2021
Current stock price$27.84$30.83
Expected volatility72.00 %71.60 %
Risk-free interest rate0.85 %0.75 %
Dividend rate0.00 %0.00 %
Expected term (years)4.965.00
Schedule of Common Stock Warrants
Activity of warrants is set forth below:

 
Legacy Warrants (1)
Private Placement WarrantsPublic Warrants
Total
Common Stock Warrants (1)
Outstanding as of January 31, 202138,761,03138,761,031
Common Stock Warrants as Part of the Merger
6,521,56810,470,56216,992,130
Warrants Exercised(3,176,428)(4,349,342)(10,226,081)(17,751,851)
Warrants Redeemed(244,481)(244,481)
Outstanding as of October 31, 202135,584,6032,172,22637,756,829
_______________
(1) The shares (and the warrants' exercise prices) subject to the Company's Legacy Warrants were restated to reflect the Exchange Ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3.